The Longevity Genes in Founder Populations Project

Last updated: December 19, 2024
Sponsor: Albert Einstein College of Medicine
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT00707694
1998-125
2U19AG056278-07A1
1R56AG088624-01
G42988
R01AG088659
3U19AG056278-06S1
P01AG021654
  • Ages > 65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of our research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Ashkenazi Jewish, age 95+,

  • Offspring of person age 95+,

  • Offspring of parents who died age 70 or younger.

Exclusion

Exclusion Criteria:

  • Non-Ashkenazis

Study Design

Total Participants: 2000
Study Start date:
July 01, 1998
Estimated Completion Date:
December 31, 2032

Connect with a study center

  • Boston University Medical Center

    Boston, Massachusetts 02118-2526
    United States

    Site Not Available

  • Private Homes

    New York, New York
    United States

    Active - Recruiting

  • Weill Cornell Medical College

    New York, New York 10065
    United States

    Active - Recruiting

  • Hebrew Home Riverdale

    Riverdale, New York 10471
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.